Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when 4D Molecular Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get FDMT alerts

About Ashoo Gupta

Ashoo Gupta is recorded as CFO at 4D Molecular Therapeutics, Inc. (FDMT) since September 30, 2025. 4D Molecular Therapeutics, Inc. reported in an 8-K filed October 2, 2025 that Ashoo Gupta was appointed Principal Financial Officer and Principal Accounting Officer, effective September 30, 2025. 4D Molecular Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at 4D Molecular Therapeutics, Inc. includes David Kirn (CEO and Board Member), David Kirn, M.D. (CEO), Kristian Humer (CFO and Chief Accounting Officer) and 7 others.

“On September 30, 2025, the Board of Directors (the "Board") of 4D Molecular Therapeutics, Inc. (the "Company") appointed Ashoo Gupta as Principal Financial Officer and Principal Accounting Officer of the Company, effective immediately.”
4D Molecular Therapeutics, Inc. Form 8-K, filed October 2, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at 4D Molecular Therapeutics, Inc.

Recent activity